| 851 |
9536982 | [Relationships between p53 induction, cell cycle arrest and survival of normal human fibroblasts following DNA damage]. | 1997 Nov |
1 |
| 852 |
9563008 | Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas. | 1997 |
3 |
| 853 |
9815601 | UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status. | 1997 Nov |
3 |
| 854 |
9815771 | Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies. | 1997 Jun |
2 |
| 855 |
21590120 | Enhancement of apoptosis in irradiated glioblastoma cells by pentoxifylline. | 1997 Jul-Aug |
1 |
| 856 |
8564971 | Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. | 1996 Feb 1 |
4 |
| 857 |
8616869 | The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. | 1996 May 1 |
3 |
| 858 |
8630996 | A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. | 1996 Feb 15 |
4 |
| 859 |
8631030 | Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. | 1996 Feb 15 |
2 |
| 860 |
8653690 | Modulation of p53 expression by human recombinant interferon-alpha2a correlates with abrogation of cisplatin resistance in a human melanoma cell line. | 1996 Jun 1 |
3 |
| 861 |
8667426 | UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. | 1996 Jul 17 |
1 |
| 862 |
8687228 | [Therapeutic effect of adenovirus-mediated transfer of the wild-type p53 gene with cisplatin]. | 1996 Jul |
1 |
| 863 |
8760308 | Induction of p53 and increased sensitivity to cisplatin in ataxia-telangiectasia cells. | 1996 Aug 1 |
2 |
| 864 |
8808702 | WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. | 1996 Sep 19 |
5 |
| 865 |
8895543 | Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line. | 1996 Sep 27 |
2 |
| 866 |
8903408 | Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene. | 1996 Nov |
1 |
| 867 |
8911337 | Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer. | 1996 Nov |
8 |
| 868 |
8920796 | Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy. | 1996 Sep-Oct |
5 |
| 869 |
8945622 | Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations. | 1996 Nov 15 |
2 |
| 870 |
8950204 | High-risk HPV-positive human cancer cell lines show different sensitivity to cisplatin-induced apoptosis correlated with the p21Waf1/Cip1 level. | 1996 Nov 12 |
2 |
| 871 |
8967975 | Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance. | 1996 Dec |
2 |
| 872 |
8968086 | p53-null cells are more sensitive to ultraviolet light only in the presence of caffeine. | 1996 Dec 1 |
1 |
| 873 |
9042268 | The dual role of mutant p53 protein in chemosensitivity of human cancers. | 1996 Nov-Dec |
1 |
| 874 |
9081399 | Ovarian cancer, from the laboratory to the clinic: challenges for the future. | 1996 Jan |
1 |
| 875 |
7478541 | The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. | 1995 Oct 5 |
1 |
| 876 |
7585548 | Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer. | 1995 Nov 1 |
5 |
| 877 |
7588628 | DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective. | 1995 Oct 16 |
1 |
| 878 |
7712469 | Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. | 1995 Apr 15 |
8 |
| 879 |
7729416 | Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. | 1995 Apr 3 |
1 |
| 880 |
7761100 | MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis. | 1995 May 18 |
2 |
| 881 |
8519417 | Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53. | 1995 Dec |
3 |
| 882 |
8521409 | Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells. | 1995 Dec 15 |
2 |
| 883 |
7954409 | p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. | 1994 Nov 15 |
2 |
| 884 |
8406999 | Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. | 1993 Oct 21 |
11 |
| 885 |
8485705 | Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. | 1993 May 15 |
1 |
| 886 |
21573382 | P53 expression in end-stage squamous-cell carcinoma of the head and neck prior to chemotherapy treatment - expression correlates with a very poor clinical outcome. | 1993 Sep |
1 |